News from the New England Consortium Node & CTN-0100/RDD Update

At the CTN Quarterly Steering Committee Meeting on September 15, 2026, NECN member, Zoe Weinstein, MD, MS, co-led the final study report for the CTN-0098 along with study Co-Lead Investigator, Gavin Bart, MD, PhD, FACP, FASAM. Dr. Weinstein serves as the Site PI for the Boston University site for both CTN-0098A and CTN-0098B.

NECN member, Richard Saitz, MD, MPH, FACP, DFASAM, study Co-Lead Investigator, passed away during the study, and he was acknowledged and honored as a leader and innovator of the study.

CTN-0100/RDD study update

This publication from the CTN-0100 RDD Study has over 3,000 views!

Research ethics in stopping opioid use disorder medication [editorial].
Weiss, Roger D.; Nunes, Edward V.; Provost, Scott E. JAMA Psychiatry 2026;83(5):439-440. Find it in the CTN Dissemination Library

The CTN-0100 primary outcome paper for the Retention Phase is in preparation.

Posted on September 17, 2026